At a Glance

• Director of Research for the Lunenfeld; Koffler Directorship for the Samuel Lunenfeld Research Institute
• Researches the manipulation of cell processes to treat certain cancers, diabetes and neurodegenerative conditions
• Focuses on regulatory proteins called kinases -- the master switches in cells that control responses to the environment
• Harvests adult stem cells – which hold great promise for the treatment and cure of life-threatening illnesses

Major Research Activities

Dr. Woodgett's group is studying the molecular mechanisms by which the Wnt and PI3K pathways are dysregulated in human cancers such as breast and colon cancer. His laboratory is also studying the roles of signaling pathways in type-2 diabetes and stem cell fate determination and has a long-standing interest in genomics applications such as DNA microarrays and protein arrays.

Recent Publications